3-(Trifluoromethyl)Pyridine-2-Carboxylic Acid 98.0%(GC)

Fidaxomicin (trade names Dificid Dificlir and previously OPT-80 and PAR-101) is the first in a new class of narrow spectrum macrocyclic antibiotic drugs. It is a fermentation product obtained from the actinomycete Dactylosporangium aurantiacum subspecies hamdenesis. Fidaxomicin is non-systemic meaning it is minimally absorbed into the bloodstream it is bactericidal and it has demonstrated selective eradication of pathogenic Clostridium difficile with minimal disruption to the multiple species of bacteria that make up the normal healthy intestinal flora.

For R&D use onlynot for drug household or other uses.

Fidaxomicin(OPT-80 PAR-101) is a new class of narrow spectrum macrocyclic antibiotic drug selective eradication of pathogenic Clostridium difficile with minimal disruption to the multiple species of bacteria that make up the normal healthy intestinal flora.